Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dia Mundial da Menopausa: ressecamento e baixa produção de colágeno são alguns dos sintomas que afetam a pele nesse período


News provided by

Galderma

Oct 16, 2023, 15:40 ET

Share this article

Share toX

Share this article

Share toX

Em celebração ao Dia Mundial da Menopausa, em 18 de outubro, dermatologistas explicam como procedimentos estéticos pouco invasivos podem ser soluções para uma pele mais firme e hidratada

SÃO PAULO, 16 de outubro de 2023 /PRNewswire/ -- Conforme a idade avança, o tema "menopausa" passa a ganhar relevância entre as pessoas que sabem que irão passar por essa fase. Na prática, esse período tem como uma das suas principais características o encerramento da produção de hormônios como estrogênio e progesterona e acontece entre os 45 e 55 anos de idade1. Diante dessa mudança no organismo, há o surgimento de diversos efeitos colaterais no corpo. De acordo com o IBGE, cerca de 29 milhões de pessoas estão no período entre o climatério, termo que indica a transição do período reprodutivo e não reprodutivo, e a menopausa2.

Os sintomas podem variar de pessoa para pessoa, mas os mais comuns são as ondas de calor, infecção urinária de repetição, baixa libido, dor nas articulações, ressecamento da pele e do cabelo, e queda da produção de colágeno1, que causa flacidez de pele. Segundo a dermatologista Dra. Samela Rosique (CRM-RO 3527), a diminuição dos hormônios no período da menopausa faz com que a pele passe por mudanças significativas, que agravam e tornam mais aparente o ressecamento e marcas de expressão, por exemplo.

Em casos como esse, tratamentos estéticos minimamente invasivos como o uso de ácido hialurônico injetável podem auxiliar pacientes a recuperar o viço e hidratação da pele com um efeito prolongado. "O procedimento forma reservatórios de ácido hialurônico na derme, o que melhora a maciez e aspecto da pele, mantém a hidratação e restaura o viço e elasticidade", explica a dermatologista.

Uma das opções para esse tratamento é Restylane®, a linha de ácido hialurônico injetável mais segura3 e completa do mercado4, pois conta com diferentes tipos de géis para necessidades específicas, que podem proporcionar hidratação, melhorar linhas finas5 e cicatrizes de acne6. O produto pode ser aplicado no pescoço, colo e mãos para melhorar a hidratação da região tratada e amenizar a rugosidade da pele7,8. O procedimento tem durabilidade de até 36 meses com dois retratamentos durante esse período9.

Outro sintoma que pode incomodar algumas pessoas é a flacidez de pele por conta da diminuição da produção de colágeno. Essa diminuição natural, que é em média de 1% a partir dos 20 anos de idade10, se intensifica com a perda de estrogênio, característica da menopausa, aumentando a perda de colágeno em até 2% ao ano11 e influenciando também no ressecamento e flacidez da pele.

"Para pacientes que estão passando pela menopausa e procuram melhorar a produção de colágeno e tratar a flacidez da pele em regiões como rosto, colo, pescoço, coxas, abdômen, braços, glúteos e mãos, eu recomendo a aplicação do bioestimulador de colágeno. É um procedimento injetável, realizado em consultório e minimamente invasivo, que traz resultados eficazes e de longa duração, como a melhora da firmeza e textura da pele", explica a dermatologista Dra. Natália Nascif (CRM-ES 11560).

Para esse tratamento, uma solução é o bioestimulador de colágeno Sculptra®, que pode ajudar no tratamento da flacidez, pois aumenta a produção de colágeno em 66,5%12, proporcionando sustentação e firmeza de pele gradualmente e podendo ser aplicado não apenas na face13, mas também no pescoço, colo, braços, abdômen, coxas, glúteos e joelhos14,15, com resultados que podem durar mais de dois anos16.

Ainda segundo Dra. Natália, o tratamento com bioestimulador de colágeno pode também ser conjugado com a aplicação do ácido hialurônico injetável, para resultados ainda melhores e que vão garantir uma pele mais hidratada, atenuando os sinais da menopausa na pele.

Para além de questões estéticas, a realização desses procedimentos para tratar os sintomas da menopausa na pele trará benefícios para a autoestima e saúde de quem está passando por esse período. Por isso, adotar um estilo de vida mais saudável, realizar o skincare e consultar um profissional da saúde são boas dicas para passar por essa fase da vida de bem consigo mesmo!

Sculptra® e Restylane® são produtos utilizados em procedimentos estéticos que devem ser aplicados por profissionais de saúde habilitados a essa prática.

1Biblioteca Virtual em Saúde. Menopausa e climatério. Disponível em https://bvsms.saude.gov.br/menopausa-e-climaterio/. Acesso em 14 de setembro de 2023.

2Fundação Oswaldo Cruz. Projeto Flor de Cammelia - Climatério e Menopausa. Disponível em https://saudedapessoaidosa.fiocruz.br/projeto-flor-de-cammelia-climaterio-e-menopausa#:~:text=De%20acordo%20com%20estimativas%20publicadas,9%25%20da%20popula%C3%A7%C3%A3o%20feminina%20brasileira. Acesso em 14 de setembro de 2023.

3Sadeghpour M, et al. Delayed-Onset Nodules to Differentially Crosslinked Hyaluronic Acids: comparative Incidence and Risk Assessment. Dermatol Surg 2019;45:1085–1094

4Rzany B., Bayerl C., Bodokh I. et al. Eficacy and safety of a new hyaluronic acid dermal filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther 2011;13:107-112

5Nikolis A and Enright KM. Evaluating the role of small particle hyaluronic acid fillers using micro-droplet technique in the face, neck and hands: a retrospective chart review. Clin Cosmet Investig Dermatol.2018:11 467–475

6Dierickx C, Larsson MK, Blomster S. Effectiveness and Safety of Acne Scar Treatment With Nonanimal Stabilized Hyaluronic Acid Gel. Dermatol Surg 2018;44(Suppl 1) :S10-S18.

7Bertucci V. and Lynde CB. Current Concepts in the Use of Small-Particle Hyaluronic Acid. Plast. Reconstr Surg. 2015; 136: 132S, 2015

8Streker M et al. Stabilized hyaluronic acid-based gel oh non-animal origin for skin rejuvenation: face, hand and décolletage.J Drugs Dermatol. 2013; 12(9):990-4

9Narins R.S., Brandt F.S., Dayan S.H. et al. Persistence of nasolabial fold correction with a hyaluronic acid dermal filler with retreatment: results of an 18-month extension study. Dermatol Surg. 2011 May;37(5):644-50

10Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93:639-643

11Sociedade Brasileira de Dermatologia do Rio de Janeiro. O que a menopausa é capaz de fazer com a pele? Disponível em https://sbdrj.org.br/o-que-a-menopausa-e-capaz-de-fazer-com-a-pele/. Acesso em 14 de setembro de 2023.

12Goldberg D.Guana A, Volk A, Daro Kaftan E. Single arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg.2013.39(6):915 922.

13Machado Filho CDS, Santos TC, Rodrigues APLJ, da Cunha MG. Ácido poli-L-láctico: um agente bioestimulador. Surg Cosmet Dermatol. 2013;5(4):345-50.

14Haddad A, Menezes A, Guarnieri C, et al. Recommendations on the Use of Injectable Poly-L-Lactic Acid for Skin Laxity in Off-Face Areas. J Drugs Dermatol. 2019;18(9):929-935.

15Kollipara R, Hoss E, Boen M, Alhaddad M, Fabi SG. A Randomized, Split-Body, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Poly-L-lactic Acid for the Treatment of Upper Knee Skin Laxity. Dermatol Surg. 2020 Dec;46(12):1623-1627

16Narins R, Baumann L, Brandt F et al. A randomized study of the efficacy and safety of Injectable poly-l-lactic acid versus human–based collagen implant in the treatment. J Am Acad Dermatol. 2010 Mar;62(3):448-62

Sobre a Galderma 

A Galderma é a empresa líder na categoria dedicada ao avanço de soluções para o cuidado da pele, presente em aproximadamente 90 países. Fornecemos um portfólio inovador e baseado em ciência de marcas e serviços premium que abrangem todo o espectro de dermatologia em rápido crescimento por meio de Estética Injetável, Skincare Dermatológico e Dermatologia Terapêutica. Desde nossa fundação em 1981, dedicamos nosso foco e paixão ao maior órgão do corpo humano – a pele – atendendo às necessidades individuais de consumidores e pacientes com resultados superiores em parceria com profissionais de saúde. Estamos avançando a dermatologia para cada história de pele, porque entendemos que a pele em que estamos molda nossas histórias de vida. O portfólio de marcas emblemáticas da Galderma inclui Restylane e Sculptra em Estética Injetável; Cetaphil, Dermotivin e Benzac em Skincare Dermatológico; além dos medicamentos prescritos para Acne e Rosácea em Dermatologia Terapêutica.

Para mais informações: www.galderma.com.br e www.galdermaaesthetics.com.br

FONTE Galderma

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.